Biohaven Announces Pricing of $250 Million Public Offering of Common Shares

Group 1 - Biohaven Ltd. announced the pricing of its public offering of 5,263,158 common shares at $47.50 per share, with expected gross proceeds of approximately$250 million [1] - The offering includes a 30-day option for underwriters to purchase an additional 789,473 common shares at the public offering price [1] - The offering is expected to close on October 2, 2024, subject to customary closing conditions [1] Group 2 - J.P. Morgan, Morgan Stanley, Jefferies, and TD Cowen are acting as the joint lead book-running managers for the offering [2] - The shares will be issued under an effective shelf registration statement on Form S-3 [4]